期刊
PATHOGENS
卷 12, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/pathogens12070964
关键词
immunity; mass spectrometry; proteomics; ADP-ribosylation; poly(ADP-ribose) glycohydrolase; Diphtheria toxin-like ADP-ribosyltransferases; chronic infection; arboviruses; cardiovascular disease; emphysema; alcoholic liver disease; SARS-CoV-2; host-pathogen interactions
类别
Aberrant adenosine diphosphate-ribose (ADP)-ribosylation is linked to various diseases. In this review, the roles of PARP1/ARTD1, PARP7/ARTD14, PARP9/ARTD9, and PARP14/ARTD8 in macrophages are discussed. PARPs/ARTs regulate macrophage changes in chronic inflammation through catalytic and non-catalytic mechanisms. Understanding these complex mechanisms and developing innovative technologies are crucial for the development of new therapeutics.
Aberrant adenosine diphosphate-ribose (ADP)-ribosylation of proteins and nucleic acids is associated with multiple disease processes such as infections and chronic inflammatory diseases. The poly(ADP-ribose) polymerase (PARP)/ADP-ribosyltransferase (ART) family members promote mono- or poly-ADP-ribosylation. Although evidence has linked PARPs/ARTs and macrophages in the context of chronic inflammation, the underlying mechanisms remain incompletely understood. This review provides an overview of literature focusing on the roles of PARP1/ARTD1, PARP7/ARTD14, PARP9/ARTD9, and PARP14/ARTD8 in macrophages. PARPs/ARTs regulate changes in macrophages during chronic inflammatory processes not only via catalytic modifications but also via non-catalytic mechanisms. Untangling complex mechanisms, by which PARPs/ARTs modulate macrophage phenotype, and providing molecular bases for the development of new therapeutics require the development and implementation of innovative technologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据